ContractConfidentiality Agreement • July 5th, 2022 • Artemis Therapeutics, Inc. • Miscellaneous chemical products
This is a translation into English of the official Hebrew version of the agreement between Manuka Ltd. and Chic Cosmetics Industries 1989 Ltd. In the event of a conflict between the English and Hebrew texts, the Hebrew text shall prevail.
DEBT FORGIVENESS AGREEMENTDebt Forgiveness Agreement • July 5th, 2022 • Artemis Therapeutics, Inc. • Miscellaneous chemical products • Delaware
THIS DEBT FORGIVENESS AGREEMENT (this “Agreement”) is made and entered into and effective as of this __th day of _____, 2022 by and between Artemis Therapeutics, Inc., a Delaware corporation (“Artemis”), and _____________ (the “Lender”).
FIRST AMENDMENT TO SHARE EXCHANGE AGREEMENTShare Exchange Agreement • July 5th, 2022 • Artemis Therapeutics, Inc. • Miscellaneous chemical products
This First Amendment to the Share Exchange Agreement, dated as of June 30, 2022 (this “Amendment”), is by and among Artemis Therapeutics, Inc., a corporation organized under the laws of the State of Delaware, having an office for the transaction of business at 8 East 16th Street, Suite 307, New York, NY 10003 (“Purchaser”), MANUKA Ltd., a limited liability company organized under the laws of the State of Israel, having an office for the transaction of business at 19 Haim Barlev Street, Ramat Gan, 5265368, Israel (“MANUKA” or “Company”), and the shareholders of MANUKA listed on the signature page and Exhibit A attached hereto, constituting all of the security holders of MANUKA (collectively, the “Shareholders” and individually a “Shareholder”), each having an address set forth on Exhibit A hereto. Each of Purchaser, MANUKA and the Shareholders is sometimes referred to herein as a “Party” and collectively as the “Parties.”
AGREEMENTAgreement • July 5th, 2022 • Artemis Therapeutics, Inc. • Miscellaneous chemical products • Auckland
This Agreement (the “Agreement”) is made as of July 20, 2021 (the “Effective Date”) by and between Waitemata Manuka Honey Direct Ltd (“WMHD”), and Waitemata Honey Co Ltd (“WHC”), organized under the laws of New Zealand, with offices at 8 Te Kea Place, Rosedale Industrial Centre, Auckland, NZ (jointly referred to as the “Companies”) and MANUKA LTD, a limited company organized and existing under the laws of the State of Israel, with offices at 19 Haim Bar-Lev St., Ramat-Gan, Israel (the “Reseller”).
ARTEMIS THERAPEUTICS, INC.Warrant Exchange Agreement • July 5th, 2022 • Artemis Therapeutics, Inc. • Miscellaneous chemical products • New York
Reference is made to that certain Warrant issued by Artemis Therapeutics, Inc., a Delaware corporation (the “Company”), to ___________ (the “Holder”), dated as of October 23, 2017 (the “Warrants”), attached hereto as Exhibit A, pursuant to which the Company granted the Holder a right to acquire up to an aggregate of _______ shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company at a per share exercise price of $2.00 (subject to certain adjustments as provided in the Warrant). The Warrant was issued by the Company pursuant to that certain Securities Purchase Agreement dated October 23, 2017 by and among the Company and the Holder (the “Securities Purchase Agreement”). Capitalized terms not otherwise defined herein shall have the meanings given to them in the Securities Purchase Agreement and the Warrant.
